Skip to Content

Philips, ResMed highlight research on World Sleep Day

Philips, ResMed highlight research on World Sleep Day

AMSTERDAM, the Netherlands - Adults recognize that sleep is important, but they still prioritize other things in their lives over sleep, according to a new international survey published by Royal Philips on World Sleep Day.

Ninety-two percent of 6,461 adults across five countries who were surveyed by Harris Poll said sleep is crucial to their overall health and wellbeing. They say even one bad night of sleep can result in looking tired, being less productive and feeling unmotivated.

Yet 84% of adults say other things in their lives are more important than a good night's sleep, including family time and job responsibilities.

Twenty-eight percent of adults also say that, despite all the literature that screens should be turned off well before sleep, watching TV is the last thing they do before bed.

“Sleep is vitally important to the 'healthy lifestyle' equation, but it is often cast aside as less important compared to the other fundamental elements such as eating well or exercising,” said Dr. Teofilo Lee-Chiong, sleep clinician and chief medical liaison, Philips. “We need to start thinking of health and wellness as a table with four legs, each of which representing proper nutrition, exercise, positive mental health and sleep—if we're only focusing on diet and exercise, that table isn't going to be balanced.”

Philips aims to use the survey, “Unfiltered Sleep: A Global Prioritization Puzzle,” to start a conversation about the importance of sleep to overall health and wellbeing.

ResMed highlights sleep research

SAN DIEGO - ResMed has picked the top five research findings among more than 3,000 studies published last year in recognition of World Sleep Day.

“Unnecessary hospital readmissions and inefficient practices are huge drivers of today's exorbitant healthcare costs,” said Adam Benjafield, ResMed vice president of medical affairs. “Recognizing sleep apnea is associated with many other life-threatening conditions and knowing early detection makes a world of difference, treatment efficacy and efficiency have become even more paramount. The research we've highlighted today shows that we're moving in the right direction.”

Summaries of the research are:

  • There is a high prevalence of sleep-disordered breathing among stable chronic heart failure patients (Arzt M et al. JACC Heart Fail 2016).Of 6,876 stable chronic heart failure (CHF) patients across 138 German centers, the prevalence of moderate to severe sleep-disordered breathing (SDB) was 46%, with a significant difference seen between thesexes (36% in women vs. 49% in men). Risk factors included body mass index, left ventriculardysfunction, age, atrial fibrillation and male sex.
  • Early recognition of obstructive sleep apnea in patients hospitalized with COPD exacerbation isassociated with reduced readmission rates (Konikkara J et al. Hosp Pract 2016).Patients consulted for COPD exacerbation underwent a sleep test upon discharge and received positive airwaypressure (PAP) therapy as appropriate. The mean change in the number of clinical events six months prior tointervention compared to six months following intervention favored the group who used their PAP therapy,demonstrating early recognition and treatment of obstructive sleep apnea (OSA) in patients admitted withCOPD exacerbation may be associated with reduced hospital admission rates and emergency room visits.
  • CPAP significantly improves quality of life, sleepiness and cerebrovascular measures in patients with obstructive sleep apnea (McEvoy RD et al. N Engl J Med 2016).While results in the landmark SAVE trial were neutral on the primary endpoint of whether CPAP can reducemajor cardiovascular events in those with OSA and heart disease, the 2,700-patient study did show that CPAPcan significantly improve the quality of life for people with OSA, and—when used more than four hours pernight—may also lower the risk of stroke and other cerebral events.
  • Access to digital engagement tools improves patient compliance on CPAP therapy (Crocker M et al.CHEST (Suppl) 2016). A study of 128,000 sleep apnea patients found patients with access to digital engagement tools demonstratedimproved adherence to CPAP therapy over a three-month period. Nearly 90% of patients using a patientengagement tool in the study reached this important healthcare standard—a 24% relative increase overpatients who were only managed remotely by a provider.
  • A telehealth program for CPAP adherence reduces labor and yields similar adherence and efficacywhen compared to standard care (Munafo D et al. Sleep Breath 2016).A study evaluating the effectiveness and coaching labor requirements of a web-based automated telehealthmessaging program compared to standard care in newly diagnosed OSA patients found a significant reductionin the number of minutes coaching required per patient in the telehealth vs. standard of care group (23.9 vs.58.3). The majority of patients in this group stated the new approach met or exceeded their expectations.

Comments

To comment on this post, please log in to your account or set up an account now.